What is the dosage of amoxicillin (amoxicillin-clavulanate) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing in Pediatric Patients

The standard dosage of amoxicillin-clavulanate for pediatric patients is 45 mg/kg/day of the amoxicillin component divided into 3 doses or 90 mg/kg/day divided into 2 doses for β-lactamase producing organisms. 1

Age-Based Dosing Recommendations

Neonates and Infants <12 weeks (<3 months)

  • 30 mg/kg/day divided every 12 hours, based on the amoxicillin component 2
  • Use of the 125 mg/5 mL oral suspension is recommended for this age group 2

Patients ≥12 weeks (≥3 months)

  • For otitis media, sinusitis, lower respiratory tract infections, and more severe infections:
    • 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours 2
  • For less severe infections:
    • 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours 2
  • The twice-daily regimen is preferred as it is associated with significantly less diarrhea 2

Patients Weighing ≥40 kg

  • Should be dosed according to adult recommendations 2
  • The 250 mg/125 mg tablets should not be used until the child weighs at least 40 kg due to different amoxicillin to clavulanic acid ratios 2

High-Dose Regimen

  • High-dose amoxicillin-clavulanate is defined as 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in two divided doses for children 3
  • This regimen is recommended for areas with high prevalence of penicillin-resistant Streptococcus pneumoniae (>10%) 1
  • The high-dose formulation provides a 14:1 ratio of amoxicillin to clavulanate in an oral suspension 3
  • This higher dose is particularly important for treating acute otitis media caused by penicillin-intermediate and -resistant S. pneumoniae 4

Specific Indications and Dosing

Acute Otitis Media

  • For recurrent or persistent AOM after failure of amoxicillin alone, high-dose amoxicillin/clavulanate (90 mg/kg/day of amoxicillin component) is recommended 4, 5
  • Treatment duration should be 10 days 2
  • The high-dose formulation has shown similar tolerability to conventional twice-daily formulation (45/6.4 mg/kg/day) 4

Respiratory Tract Infections

  • For β-lactamase producing H. influenzae, amoxicillin-clavulanate at 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses is recommended 3
  • The standard pediatric dose of 40-45 mg/kg/day may be inadequate to effectively eradicate resistant S. pneumoniae, particularly during viral coinfection 6

Important Clinical Considerations

  • Twice-daily dosing is associated with better compliance and less diarrhea than three-times-daily dosing 4
  • A reduced-clavulanate formulation (80 mg amoxicillin/2.85 mg clavulanate/kg/day) may be associated with fewer side effects (particularly diaper dermatitis) without reducing clinical efficacy 7
  • Serum levels of amoxicillin increase linearly with the dose, and the difference in the incidence of adverse effects between lower and higher doses is generally negligible 3
  • Common adverse effects include diarrhea, nausea, vomiting, and rash 3

Dosage Adjustments

  • Patients with impaired renal function generally do not require a reduction in dose unless the impairment is severe 2
  • For children with glomerular filtration rate <30 mL/min, dosage adjustment is necessary 2

By following these dosing guidelines, clinicians can optimize treatment outcomes while minimizing adverse effects in pediatric patients requiring amoxicillin-clavulanate therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.